Last reviewed · How we verify
Magnesium with ropivacaine
At a glance
| Generic name | Magnesium with ropivacaine |
|---|---|
| Also known as | MR |
| Sponsor | Aristotle University Of Thessaloniki |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair (PHASE4)
- Tramadol / Magnesium in Ropivacaine Solution in UG-bilateral TAP Block and Analgesia in Robotic Radical Prostatectomy (NA)
- The Efficacy and Safety of Magnesium Sulphate Adjuvant in Scalp Block With Ropivacaine for Supratentorial Craniotomy: a Prospective, Randomized Controlled Trial (PHASE4)
- Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair (PHASE4)
- Magnesium as Adjuvant for Sciatic Block (NA)
- Ropivacaine Plus Magnesium Sulphate Infiltration (PHASE4)
- Respiratory Impact of LA Volume After IS Block (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Magnesium with ropivacaine CI brief — competitive landscape report
- Magnesium with ropivacaine updates RSS · CI watch RSS
- Aristotle University Of Thessaloniki portfolio CI